UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

What has been learnt from the thrombin‐activatable fibrinolysis inhibitor‐deficient mouse?

Journal of thrombosis and haemostasis, 2010-05, Vol.8 (5), p.868-876

2010

Volltextzugriff (PDF)

Enhanced wound healing by topical application of ointment containing a low concentration of povidone-iodine

Journal of wound care, 2016-09, Vol.25 (9), p.521

2016

Volltextzugriff (PDF)

Procaterol Suppresses Epithelial to Mesenchymal Transition (EMT) of Bronchial Epithelial Cells Induced By Eosinophils

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB222-AB222

2015

Volltextzugriff (PDF)

Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications

Immunobiology (1979), 2013-04, Vol.218 (4), p.470-476

2013

Volltextzugriff (PDF)

Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) Levels are decreased in Patients With Trauma-Induced Coagulopathy

Thrombosis research, 2013-01, Vol.131 (1), p.e26-e30

2013

Volltextzugriff (PDF)

Circulating fibrocytes correlate with the asthma control test score

Allergologia et immunopathologia, 2016-05, Vol.44 (3), p.191

2016

Volltextzugriff (PDF)

High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double‐deficient mice

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2514-2522

2010

Volltextzugriff (PDF)

Pulmonary hypertension is ameliorated in mice deficient in thrombin‐activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.808-816

2010

Volltextzugriff (PDF)

IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis

British journal of dermatology (1951), 2009-06, Vol.160 (6), p.1172-1179

2009

Volltextzugriff (PDF)

Eosinophils Promote Epithelial To Mesenchymal Transition Of Bronchial Epithelial Cells

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB117-AB117

2012

Volltextzugriff (PDF)

Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy‐associated tubulointerstitial fibrosis

Journal of thrombosis and haemostasis, 2008-01, Vol.6 (1), p.139-146

2008

Volltextzugriff (PDF)

Protective Effect of Thrombomodulin in a Murine Model of Allergen-Induced Asthma

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB64-AB64

2011

Volltextzugriff (PDF)

Protective role of protein C inhibitor in monocrotaline‐induced pulmonary hypertension

Journal of thrombosis and haemostasis, 2006-11, Vol.4 (11), p.2331-2339

2006

Volltextzugriff (PDF)

Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (7), p.1477-1485

2007

Volltextzugriff (PDF)

EP12.01-34 Autopsy and Next Generation Sequencing Report of First-Line Treatment with Osimertinib for EGFR-Mutated Squamous Cell Carcinoma of the Lung

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S653-S654

2023

Volltextzugriff (PDF)

Protein S is protective in pulmonary fibrosis

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1588-1599

2016

Volltextzugriff (PDF)

1535P Efficacy and safety of amrubicin after treatment with immune checkpoint inhibitor combined with chemotherapy in extensive-stage small cell carcinoma: MiSSION1

Annals of oncology, 2022-09, Vol.33, p.S1249

2022

Volltextzugriff (PDF)

Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions

Journal of thrombosis and haemostasis, 2004-06, Vol.2 (6), p.949-961

2004

Volltextzugriff (PDF)

気管内転移を呈した無色素性悪性黒色腫の1例

気管支学, 2017/09/25, Vol.39(5), pp.407-411

2017

Volltextzugriff (PDF)

Protein S exacerbates alcoholic hepatitis by stimulating liver natural killer T cells

Journal of thrombosis and haemostasis, 2015-01, Vol.13 (1), p.142-154

2015

Volltextzugriff (PDF)

Activation of protein C pathway in the airways

Lung, 2002-01, Vol.180 (1), p.47-59

2002

Volltextzugriff (PDF)

Dose‐dependent differential effects of thrombin in allergic bronchial asthma

Journal of thrombosis and haemostasis, 2013-10, Vol.11 (10), p.1903-1915

2013

Volltextzugriff (PDF)

Exogenous activated protein C inhibits the progression of diabetic nephropathy

Journal of thrombosis and haemostasis, 2012-03, Vol.10 (3), p.337-346

2012

Volltextzugriff (PDF)

Heat-killed bacillus Calmette-Guérin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells

British journal of dermatology (1951), 2012-05, Vol.166 (5), p.953-963

2012

Volltextzugriff (PDF)

Direct effects of protein S in ameliorating acute lung injury

Journal of thrombosis and haemostasis, 2009-12, Vol.7 (12), p.2053-2063

2009

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(36)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What has been learnt from the thrombin‐activatable fibrinolysis inhibitor‐deficient mouse?

Enhanced wound healing by topical application of ointment containing a low concentration of povidone-iodine

Procaterol Suppresses Epithelial to Mesenchymal Transition (EMT) of Bronchial Epithelial Cells Induced By Eosinophils

Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications

Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) Levels are decreased in Patients With Trauma-Induced Coagulopathy

Circulating fibrocytes correlate with the asthma control test score

High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double‐deficient mice

Pulmonary hypertension is ameliorated in mice deficient in thrombin‐activatable fibrinolysis inhibitor

IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis

Eosinophils Promote Epithelial To Mesenchymal Transition Of Bronchial Epithelial Cells

Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy‐associated tubulointerstitial fibrosis

Protective Effect of Thrombomodulin in a Murine Model of Allergen-Induced Asthma

Protective role of protein C inhibitor in monocrotaline‐induced pulmonary hypertension

Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator

EP12.01-34 Autopsy and Next Generation Sequencing Report of First-Line Treatment with Osimertinib for EGFR-Mutated Squamous Cell Carcinoma of the Lung

Protein S is protective in pulmonary fibrosis

1535P Efficacy and safety of amrubicin after treatment with immune checkpoint inhibitor combined with chemotherapy in extensive-stage small cell carcinoma: MiSSION1

Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions

気管内転移を呈した無色素性悪性黒色腫の1例

Protein S exacerbates alcoholic hepatitis by stimulating liver natural killer T cells

Activation of protein C pathway in the airways

Dose‐dependent differential effects of thrombin in allergic bronchial asthma

Exogenous activated protein C inhibits the progression of diabetic nephropathy

Heat-killed bacillus Calmette-Guérin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells

Direct effects of protein S in ameliorating acute lung injury

Suchergebnisse filtern